Floatz logo

IMIPENEM

Anti-Bacterial Agents

Children's Hospital of Fudan UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Anti-Bacterial Agents cohort.

View all 11

Same molecule, other indications

IMIPENEM is also rated in:

Critical IllnessDormant
BB
Indicative ·
65 / 100
View asset →
bacterial pneumoniaDormant
BB
Indicative ·
65 / 100
View asset →
cystic fibrosisDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →